Background & Aims Chronic liver disease (CLD) represents a major global health burden.
We undertook this study to identify the factors associated with adverse outcomes in patients …

Background & Aims Chronic liver disease (CLD) and cirrhosis are associated with immune
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …

Background & Aims Coronavirus disease 2019 (COVID-19) poses a major health threat to
healthy individuals and those with comorbidities, but its impact on patients with cirrhosis is …

Background Scientific evidence is lacking regarding the risk of patients with chronic liver
disease (CLD) for COVID-19, and how these risks are affected by age, gender and race …

Methods We searched for studies reporting COVID-19 outcomes among CLD and non-CLD
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …

Liver injury has been described with COVID‐19, and early reports suggested 2%‐11% of
patients had chronic liver disease (CLD). In this multicentre retrospective study, we …

Background & Aims In patients with chronic liver disease (CLD) with or without cirrhosis,
existing studies on the outcomes with severe acute respiratory syndrome coronavirus 2 …

Introduction and objectives The coronavirus disease 2019 (COVID-19) pandemic has been
a challenge globally. In severe acute respiratory syndrome (SARS) epidemic 60% of …

Objective Comorbid conditions are associated with poor prognosis in COVID-19. Registry
data show that patients with cirrhosis may be at high risk. However, outcome comparisons …

COVID-19 has rapidly become a global challenge. 1 We read with interest the article by
Bezzio et al1 that reported the characteristics and outcomes of COVID-19 patients with pre …